Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

145 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
PD-1 derived CA-170 is an oral immune checkpoint inhibitor that exhibits preclinical anti-tumor efficacy.
Sasikumar PG, Sudarshan NS, Adurthi S, Ramachandra RK, Samiulla DS, Lakshminarasimhan A, Ramanathan A, Chandrasekhar T, Dhudashiya AA, Talapati SR, Gowda N, Palakolanu S, Mani J, Srinivasrao B, Joseph D, Kumar N, Nair R, Atreya HS, Gowda N, Ramachandra M. Sasikumar PG, et al. Among authors: gowda n. Commun Biol. 2021 Jun 8;4(1):699. doi: 10.1038/s42003-021-02191-1. Commun Biol. 2021. PMID: 34103659 Free PMC article.
A Rationally Designed Peptide Antagonist of the PD-1 Signaling Pathway as an Immunomodulatory Agent for Cancer Therapy.
Sasikumar PG, Ramachandra RK, Adurthi S, Dhudashiya AA, Vadlamani S, Vemula K, Vunnum S, Satyam LK, Samiulla DS, Subbarao K, Nair R, Shrimali R, Gowda N, Ramachandra M. Sasikumar PG, et al. Among authors: gowda n. Mol Cancer Ther. 2019 Jun;18(6):1081-1091. doi: 10.1158/1535-7163.MCT-18-0737. Epub 2019 Apr 23. Mol Cancer Ther. 2019. PMID: 31015307
ODM-203, a Selective Inhibitor of FGFR and VEGFR, Shows Strong Antitumor Activity, and Induces Antitumor Immunity.
Holmström TH, Moilanen AM, Ikonen T, Björkman ML, Linnanen T, Wohlfahrt G, Karlsson S, Oksala R, Korjamo T, Samajdar S, Rajagopalan S, Chelur S, Narayanan K, Ramachandra RK, Mani J, Nair R, Gowda N, Anthony T, Dhodheri S, Mukherjee S, Ujjinamatada RK, Srinivas N, Ramachandra M, Kallio PJ. Holmström TH, et al. Among authors: gowda n. Mol Cancer Ther. 2019 Jan;18(1):28-38. doi: 10.1158/1535-7163.MCT-18-0204. Epub 2018 Oct 9. Mol Cancer Ther. 2019. PMID: 30301864
An inhibitor of RORγ for chronic pulmonary obstructive disease treatment.
Desai H, Marathe M, Potdar V, Tiwari P, Joshi A, Kadam SR, Joshi AR, Kulkarni A, Bhosale V, Hadambar A, Lodhiya B, Udupa V, Behera D, Chaudhari SS, Das S, Bajpai M, Gowda N, Iyer PS. Desai H, et al. Among authors: gowda n. Sci Rep. 2022 May 24;12(1):8744. doi: 10.1038/s41598-022-12251-z. Sci Rep. 2022. PMID: 35610240 Free PMC article.
Spectrophotometric estimation of risperidone in tablets.
Jayanna BK, Devaraj TD, Roopa KP, Nagendrappa G, Kumar HR, Gowda N. Jayanna BK, et al. Among authors: gowda n. Indian J Pharm Sci. 2014 Sep;76(5):452-5. Indian J Pharm Sci. 2014. PMID: 25425761 Free PMC article.
Spectrophotometric estimation of azithromycin in tablets.
Jayanna BK, Nagendrappa G, Arunkumar, Gowda N. Jayanna BK, et al. Among authors: gowda n. Indian J Pharm Sci. 2012 Jul;74(4):365-7. doi: 10.4103/0250-474X.107076. Indian J Pharm Sci. 2012. PMID: 23626394 Free PMC article.
145 results